These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 25800514

  • 1. Synthesis, biological evaluation and modeling studies of terphenyl topoisomerase IIα inhibitors as anticancer agents.
    Qiu J, Zhao B, Zhong W, Shen Y, Lin H.
    Eur J Med Chem; 2015 Apr 13; 94():427-35. PubMed ID: 25800514
    [Abstract] [Full Text] [Related]

  • 2. Hydroxylated 2,4-diphenyl indenopyridine derivatives as a selective non-intercalative topoisomerase IIα catalytic inhibitor.
    Kadayat TM, Park C, Jun KY, Thapa Magar TB, Bist G, Yoo HY, Kwon Y, Lee ES.
    Eur J Med Chem; 2015 Jan 27; 90():302-14. PubMed ID: 25437617
    [Abstract] [Full Text] [Related]

  • 3. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
    Jun KY, Lee EY, Jung MJ, Lee OH, Lee ES, Park Choo HY, Na Y, Kwon Y.
    Eur J Med Chem; 2011 Jun 27; 46(6):1964-71. PubMed ID: 21419530
    [Abstract] [Full Text] [Related]

  • 4. 3-(3-Butylamino-2-hydroxy-propoxy)-1-hydroxy-xanthen-9-one acts as a topoisomerase IIα catalytic inhibitor with low DNA damage.
    Park SE, Chang IH, Jun KY, Lee E, Lee ES, Na Y, Kwon Y.
    Eur J Med Chem; 2013 Nov 27; 69():139-45. PubMed ID: 24013413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and biological activity of ferrocenyl indeno[1,2-c]isoquinolines as topoisomerase II inhibitors.
    Wambang N, Schifano-Faux N, Aillerie A, Baldeyrou B, Jacquet C, Bal-Mahieu C, Bousquet T, Pellegrini S, Ndifon PT, Meignan S, Goossens JF, Lansiaux A, Pélinski L.
    Bioorg Med Chem; 2016 Feb 15; 24(4):651-60. PubMed ID: 26740155
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of 2-phenylnaphthalenoids as inhibitors of DNA topoisomeraseIIα and antitumor agents.
    Chen W, Shen Y, Li Z, Zhang M, Lu C, Shen Y.
    Eur J Med Chem; 2014 Oct 30; 86():782-96. PubMed ID: 25240702
    [Abstract] [Full Text] [Related]

  • 10. Synthesis and biological evaluation of imidazopyridinyl-1,3,4-oxadiazole conjugates as apoptosis inducers and topoisomerase IIα inhibitors.
    Subba Rao AV, Vishnu Vardhan MV, Subba Reddy NV, Srinivasa Reddy T, Shaik SP, Bagul C, Kamal A.
    Bioorg Chem; 2016 Dec 30; 69():7-19. PubMed ID: 27656775
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors.
    Han X, Zhong Y, Zhou G, Qi H, Li S, Ding Q, Liu Z, Song Y, Qiao X.
    Bioorg Med Chem; 2017 Jun 15; 25(12):3116-3126. PubMed ID: 28462840
    [Abstract] [Full Text] [Related]

  • 12. N-fused imidazoles as novel anticancer agents that inhibit catalytic activity of topoisomerase IIα and induce apoptosis in G1/S phase.
    Baviskar AT, Madaan C, Preet R, Mohapatra P, Jain V, Agarwal A, Guchhait SK, Kundu CN, Banerjee UC, Bharatam PV.
    J Med Chem; 2011 Jul 28; 54(14):5013-30. PubMed ID: 21644529
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, crystal structure and antiproliferative activity of Cu(II) nalidixic acid-DACH conjugate: comparative in vitro DNA/RNA binding profile, cleavage activity and molecular docking studies.
    Arjmand F, Yousuf I, Hadda Tb, Toupet L.
    Eur J Med Chem; 2014 Jun 23; 81():76-88. PubMed ID: 24826817
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Synthesis and pharmacological evaluation of novel bisindolylalkanes analogues.
    Song YL, Dong YF, Yang T, Zhang CC, Su LM, Huang X, Zhang DN, Yang GL, Liu YX.
    Bioorg Med Chem; 2013 Dec 15; 21(24):7624-7. PubMed ID: 24262885
    [Abstract] [Full Text] [Related]

  • 19. Predicting anti-cancer activity of quinoline derivatives: CoMFA and CoMSIA approach.
    Vaidya A, Jain AK, Kumar P, Kashaw SK, Agrawal RK.
    J Enzyme Inhib Med Chem; 2011 Dec 15; 26(6):854-61. PubMed ID: 21476832
    [Abstract] [Full Text] [Related]

  • 20. Pyrroloquinolinone-based dual topoisomerase I/II inhibitor.
    Dalla Via L, Marzaro G, Ferrarese A, Gia O, Chilin A.
    Eur J Med Chem; 2014 Apr 22; 77():103-9. PubMed ID: 24631729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.